Matt De Silva
Signal active
Chief Operating Officer
Bio
Matt De Silva is the Chief Operating Officer at Pathos. He was the CEO at Notable Labs
Location
San Francisco, California, United States, North America
Social
Primary Organization
Pathos
Founded
2020
Employees
1-10
Industry
Big Data, Biotechnology, Artificial Intelligence (AI), Life Science, Medical
Jobs history
4
Builders VC
Venture Partner
Invalid date - Current
Pathos
Chief Operating Officer
Invalid date - Current
Notable Labs
Founder & Executive Chairman
2020 - Current
Endpoint Health
Advisor and Angel Investor
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Matt De Silva is the Chief Operating Officer at Pathos, based in United States, North America. With a background in Big Data, Matt De Silva has a rich history of leadership and innovation. Matt De Silva studied B.S Applied Economics & Management @ Cornell University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
Matt De Silva has made 3 investments. Their Latest investment was Seed Round - Eigen Therapeutics on Dec 08, 2022
Number of investment
3
Number of exits
0
Personal investment
3
| Annouced Date | Organization Name | Funding Round | Money Raised |
|---|---|---|---|
| Jun 22, 2021 | Enveda Biosciences | Series A - Enveda Biosciences | 51.0M |
| Sep 07, 2022 | Arpeggio Bio | Series A - Arpeggio Bio | 17.0M |
| Dec 08, 2022 | Eigen Therapeutics | Seed Round - Eigen Therapeutics | 7.0M |
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.